No abstract available
Keywords:
Clozapine; Paliperidone palmitate; Speech therapy; Tardive dystonia.
MeSH terms
-
Adult
-
Antipsychotic Agents / administration & dosage
-
Antipsychotic Agents / adverse effects*
-
Combined Modality Therapy
-
Deglutition Disorders / etiology
-
Deglutition Disorders / prevention & control
-
Delayed-Action Preparations / administration & dosage
-
Delayed-Action Preparations / adverse effects
-
Dopamine D2 Receptor Antagonists / administration & dosage
-
Dopamine D2 Receptor Antagonists / adverse effects*
-
Drug Monitoring
-
Dysarthria / etiology
-
Dysarthria / prevention & control
-
Female
-
Humans
-
Neurotoxicity Syndromes / etiology*
-
Neurotoxicity Syndromes / therapy
-
Obsessive Behavior / chemically induced
-
Obsessive Behavior / prevention & control
-
Paliperidone Palmitate / administration & dosage
-
Paliperidone Palmitate / adverse effects*
-
Speech Therapy
-
Tardive Dyskinesia / chemically induced*
-
Tardive Dyskinesia / therapy
-
Treatment Outcome
Substances
-
Antipsychotic Agents
-
Delayed-Action Preparations
-
Dopamine D2 Receptor Antagonists
-
Paliperidone Palmitate